文献速递妇科产科

子宫体浸润对IA2-IIB期宫颈癌预后的影响:多中心回顾性队列研究

Influence of uterine corpus invasion on prognosis in stage IA2-IIB cervical cancer: A multicenter retrospective cohort study.
PubMed 文献 · Gynecol Oncol · 2020-05-26

该多中心回顾性队列纳入中国11家机构1414例IA2-IIB期宫颈癌根治性子宫切除患者,病理复核发现子宫体浸润漏诊38例(13.4%)、误诊20例(1.8%)。子宫体浸润者5年DFS和OS显著短于无浸润者,其中肌层浸润≥50%是独立不良预后因素,而肌层浸润<50%或内膜浸润对结局无影响。

要点

  • 子宫体浸润诊断常被漏诊,病理复核漏诊率13.4%。
  • 肌层浸润≥50%与5年DFS和OS显著缩短独立相关。
  • 肌层浸润<50%或仅内膜浸润不影响患者结局。

核心结论

  • 子宫体浸润诊断频繁漏诊,肌层浸润≥50%是宫颈癌独立不良预后因素,而肌层浸润<50%或内膜浸润不影响结局。

研究设计与样本

  • 多中心回顾性队列研究,纳入2004至2016年中国11家机构接受根治性子宫切除的IA2-IIB期宫颈癌患者1414例。

主要发现

  • 病理复核发现子宫体浸润漏诊38例(13.4%),误诊20例(1.8%)。
  • 最终284例有子宫体浸润(内膜浸润90例[31.7%],肌层浸润<50% 105例[37.0%],肌层浸润≥50% 89例[31.3%]),1130例无子宫体浸润。
  • 有子宫体浸润者5年DFS和OS显著短于无浸润者。
  • 肌层浸润≥50%与5年DFS降低独立相关(aHR 2.307,95%CI 1.588-3.351)。
  • 肌层浸润≥50%与5年OS降低独立相关(aHR 2.736,95%CI 1.813-4.130)。

临床怎么用

  • 病理评估宫颈癌子宫体浸润时需警惕漏诊,尤其关注肌层浸润深度。
  • 肌层浸润≥50%可作为预后分层参考,肌层浸润<50%或内膜浸润不改变预后判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the associations between the presence and depth of uterine corpus invasion and survival in patients with cervical cancer. METHODS: Clinical data of patients with stage IA2-IIB cervical cancer who underwent radical hysterectomy between 2004 and 2016 were retrospectively reviewed. Uterine corpus invasion was identified from a review of uterine pathology. Independent prognostic factors for 5-year disease-free survival (DFS) and overall survival (OS) were identified using multivariate forward stepwise Cox proportional hazards regression models. RESULTS: A total of 1414 patients with stage IA2-IIB cervical cancer from 11 medical institutions in China were included. Retrospective review of the original pathology reports revealed a missed diagnosis of uterine corpus invasion in 38 (13.4%) patients and a misdiagnosis in 20 (1.8%) patients. Therefore, 284 patients with cervical cancer and uterine corpus invasion (90 [31.7%] patients had endometrial invasion, 105 [37.0%] patients had myometrial invasion <50%, and 89 [31.3%] patients had myometrial invasion ≥50%), and 1130 patients with cervical cancer without uterine corpus invasion were included in the analysis. The 5-year DFS and OS were significantly shorter for patients with uterine corpus invasion compared to patients with no uterine corpus invasion. Myometrial invasion ≥50% was an independent prognostic factor associated with decreased 5-year DFS (aHR, 2.307, 95% CI, 1.588-3.351) and 5-year OS (aHR, 2.736, 95% CI, 1.813-4.130), while myometrial invasion <50% or endometrial invasion had no effect on patient outcomes. CONCLUSIONS: Diagnosis of uterine corpus invasion is frequently missed. Myometrial invasion ≥50% within the uterine corpus was an independent factor associated with worse prognosis in patients with cervical cancer, while myometrial invasion <50% or endometrial invasion had no effect on outcomes.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. He F, Li W, Liu P, et al. Influence of uterine corpus invasion on prognosis in stage IA2-IIB cervical cancer: A multicenter retrospective cohort study. Gynecol Oncol. 2020. PMID: 32467057. doi:10.1016/j.ygyno.2020.05.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。